LexisNexis® Legal Newsroom
Allergan To Pay $600M For Off-Label Marketing Of Botox

IRVINE, Calif. (Mealey's) - Allergan Inc. said Sept. 1 that it will plead guilty to a federal misdemeanor charge related to off-label marketing of Botox and will pay a total of $600 million to the federal government in criminal and civil penalties. In addition, Allergan said it will dismiss its...